Jaguar Health JAGX
NASDAQ JAGX
$0.44 +0.00 (+0.14%)
At close: Nov 10, 2026 · 4:00 PM EST

Jaguar Health (JAGX) Deferred Taxes (2017)

Updated

Jaguar Health's Deferred Taxes came in at -$990,549 for Q4 2017.

Analysis

Jaguar Health (JAGX) Deferred Taxes (2017) Analysis & Trends

For FY2017, Jaguar Health's Deferred Taxes was -$13.18 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.79 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -56.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 202.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -860.00 Mn
10 Jaguar Health 22,951.90 -15.54 Mn 194,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -990,549.00
API Access

Jaguar Health Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=JAGX&period=max&api_key=YOUR_API_KEY